Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
The top 10 drugs losing US exclusivity in 2026
While megablockbusters naturally command significant attention, Fierce takes a chance each year to look at older medicines nearing their tumble over the patent cliff.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Kevin Dunleavy
,
Zoey Becker
Mar 16, 2026 3:00am
Fierce Madness Drug Name Tournament 2026: 1st round now open
Mar 17, 2026 6:00am
Judge pumps brakes on RFK Jr.'s vaccine overhaul
Mar 16, 2026 5:08pm
Hologic finds women’s health stagnating over 5 years of surveys
Mar 17, 2026 12:37pm
Moderna CEO pay hits $19.9M as cost cuts boost cash bonus
Mar 17, 2026 12:10pm
Rhythm's Imcivree delivers ph. 3 miss in rare genetic obesities
Mar 17, 2026 11:43am
More News
Iran war poses pharma supply threats in long-term, experts warn
Mar 17, 2026 10:41am
Fierce Madness Drug Name Tournament 2026: First round now open
Mar 17, 2026 6:00am
Meds from Amgen, GSK now offered through TrumpRx DTC platform
Mar 16, 2026 11:33am
BioMarin halts dosing, enrollment in 3 midstage Voxzogo studies
Mar 16, 2026 11:26am